Tag Archive for: MAPS
Three Phase 3 Clinical Trials that Could Legalize Psychedelics
Policy, ResearchThe road to psychedelic legalization has many paths. These 3 clinical trials have the best chances to legalize psychedelics for therapy
Canada Halts MDMA Clinical Trial Over Concerns for Participant Safety
UncategorizedDeficiancies in good clinical practices and accurate record keeping stops an MDMA clinical trial in its tracks
A Brief History of MDMA: From the CIA to Raves to Psychedelic Therapy
Culture, ResearchThe history of MDMA is fascinating, and it is still being written.
MAPS Navigates Multiple Scandals: Why Health Canada Is Reviewing MDMA Trials
ResearchA sexual misconduct scandal, a data scandal, and an elder abuse scandal haunt psychedelics leader MAPS, currently being scrutinized by Health Canada.
5 Most Important Psychedelic Clinical Trials in 2022
ResearchHere's why we think MAPS’ second Phase 3 MDMA trial is the most important psychedelic study of 2022, and 4 more that may have huge impacts.
Can Psychedelics like MDMA Cure Eating Disorders?
ResearchAnyone who has ever suffered from an eating disorder, such as anorexia or bulimia, knows that beating the mind virus is a constant struggle. While therapy can help some, for many, the situation can seem hopeless.
But it need not be.
Now,…
Psychedelic Business Spotlight – February 18
Business, Stock ReportsThis week in psychedelic business news: Nova Mentis makes progress on autism; atai donates to MAPS; Cathie Wood eyes more psychedelic stocks.
Interview with Rick Doblin, Executive Director and Founder of MAPS
PodcastsIn this episode, Rick and James Hallifax discuss MAPS’ work treating PTSD with MDMA, sending the Soviets Psychedelics, and what the future holds.
How Rick Doblin Guides Someone Through a Bad Psychedelic Trip
CultureDifficult trips could be a problem in areas where psychedelics have been decriminalized, which is why MAPS will offer a psychonaut training program.
2021: A Year in Review for the Psychedelics Business
BusinessOur resident Psychedelic Investor looks back at some of this growing industry's biggest moments and how they may shape the business in 2022.